发明名称 Sustained Release Ranolazine Formulation
摘要 1. Technical Result Providing therapeutic effectiveness of ranolazine concentration in blood plasma. 2. Essence A pharmaceutically dosed form comprises ranolazine and pH-dependent binder is used for treatment of arrhythmia, cardiac infarction, variant angina pectoris and exertional angina. 3. Field of Application Medicine.
申请公布号 GEP20043289(B) 申请公布日期 2004.02.10
申请号 GE1999AP04321 申请日期 1999.09.09
申请人 CV THERAPEUTICS, INC. 发明人 WOLFF, ANDREW, A.
分类号 A61K9/20;A61K31/495;A01N43/58;A01N43/60;A61K9/22;A61K9/28;A61K9/52;A61K31/50;A61K47/32;A61K47/34;A61K47/38;A61P9/00;A61P9/06;A61P9/10 主分类号 A61K9/20
代理机构 代理人
主权项
地址